HGH Fragment 176-191 is a synthetic 16-amino-acid peptide fragment listed for in-vitro laboratory research only. Not for human or veterinary use.
About HGH Fragment 176-191
HGH Fragment 176-191 is a synthetic peptide made of residues 176-191 of the growth hormone C-terminal region. Its sequence is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, with a disulfide bond between the two cysteines. It is used in laboratory work as a reference fragment for structure and receptor-binding studies.
The product supplied by Corex Vitality™ is an analytical reference and laboratory research compound for in vitro research use only. Browse all batch certificates on our COA and verification page.
Product specifications
| Compound |
HGH Fragment 176-191 (growth hormone residues 176-191) |
| Form |
Lyophilised (freeze-dried) powder in a sealed research vial |
| Size |
5mg (actual tested fill: 5.02mg per COA LDA22162328) |
| Sequence |
YLRIVQCRSVEGSCGF (Cys7–Cys14 disulfide) |
| Chromatographic Purity (HPLC) |
>99.44% ± 0.18% (Lingda Laboratory, View Batch COA LDA22162328) |
| Endotoxin & Sterility |
0.13 EU/mg · Sterility: PASS (No growth) |
| Availability |
In stock — UK tracked dispatch (1–2 working days) |
Storage and handling
Storage & Handling — Corex Vitality™ research vials
- As supplied: freeze-dried (lyophilised) powder in a sealed vial. Room-temperature transit is normal for dry peptides.
- Longer storage: keep the vial tightly closed in a freezer at −20 °C or colder, dry and away from light. Colder is better for long archives.
- Short-term: a laboratory fridge (2–8 °C) is fine for vials you plan to open soon.
- Before opening: let the closed vial warm to room temperature, ideally in a desiccator, so moisture does not condense on the powder. Work quickly and reseal tightly; absorbed moisture lowers the real peptide content.
- Dissolving: choose a solvent based on the sequence (see the compound note below) and test a small portion first. Swirl gently; brief sonication in a water bath can help. Do not heat.
- Once in solution: make up only what you need. Split any solution you keep into single-use aliquots, freeze at −20 °C or colder and thaw each aliquot only once. Peptides keep far less well in solution than as dry powder.
- Safety: handle in a suitable laboratory with appropriate PPE, following your institution’s safety procedures, and avoid breathing the powder. Keep out of reach of children.
Compound note: Contains a disulfide bond between two cysteines. Avoid reducing agents and strongly basic solutions, and protect from light and air.
For in-vitro laboratory research use only. Not for human or veterinary use. General guidance paraphrased from Bachem: Handling and Storage Guidelines for Peptides and Peptide Solubility.
Quality and testing
The HGH Fragment 176-191 5mg batch COA (Lingda Laboratory, Report No. LDA22162328, issued 28 Oct 2026) reports HPLC-UV/VIS purity and quantity, heavy metals (ICP-MS), endotoxin (LAL assay) and sterility results. You can inspect the full Certificate of Analysis directly via the HGH Fragment 176-191 5mg Batch COA (Report No. LDA22162328) or search by report number on our COA Verification page.
Research use only
For in-vitro laboratory research use only. Not for human or veterinary use. These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.
Reviews
There are no reviews yet.